ClinicalTrials HQ

Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

Recruiting · NCT04775706 · Registry updated 2026-08-12
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF SubjectsDigestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, intestinal disorder, malabsorption syndrome, short bowel syndromeRecruitingPhase 22026-08-12NCT04775706

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Hanmi Pharmaceutical Company Limited15

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Asklepios Klinik St. GeorgHamburgGermany1
Brigham & Women's HospitalBostonUnited States36
Central Middlesex HospitalLondonUnited Kingdom5
Centre Hospitalier Universitaire de BordeauxBordeauxFrance10
Centre Hospitalier Universitaire de NiceNiceFrance1
Hopital BeaujonClichyFrance1
Les Hospices Civils de LyonLyonFrance2
Rigshospitalet Department of Digestive Diseases, Transplantation and General Surgery Section for Intestinal FailureCopenhagenDenmark1
Salford Royal HospitalSalfordUnited Kingdom2
Samsung Medical CenterSeoulSouth Korea375
Szpital Skawina sp. z o.o.SkawinaPoland1
The Cleveland Clinic FoundationClevelandUnited States55
Universitätsklinikum TübingenTübingenGermany1
UZ LeuvenLeuvenBelgium9
Wojewodzki Specjalistyczny Szpital im. Mikołaja Pirogowa w ŁodziLodzPoland1